http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-112402600-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-542 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6031 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-40 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-195 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-105 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-385 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-106 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-46 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-62 |
filingDate | 2020-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2022-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2022-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-112402600-B |
titleOfInvention | Helicobacter pylori tetravalent virulence factor GEM particle vaccine and its preparation method and application |
abstract | The invention provides a Helicobacter pylori quadrivalent virulence factor GEM particle vaccine, a preparation method and an application, and belongs to the fields of biomedicine and bioengineering. The Helicobacter pylori tetravalent virulence factor GEM particle vaccine GEM-SAM E -FVpE provided by this application mainly displays the recombinant antigen SAM E -FVpE containing the core component SAM E and the multi-epitope peptide FVpE of the Helicobacter pylori virulence factor Prepared on the surface of GEM particles, it has good antigen surface display properties. Helicobacter pylori tetravalent virulence factor GEM particle vaccine GEM‑SAM E ‑FVpE also has good gastrointestinal tract M cell targeting, and can efficiently deliver the recombinant antigen SAM E ‑FVpE to the gastrointestinal tract M cells, Stimulate the gastrointestinal tract to produce specific mucosal immune responses against various virulence factors of Helicobacter pylori. Helicobacter pylori tetravalent virulence factor GEM particle vaccine GEM-SAM E -FVpE can be used to prevent and treat Helicobacter pylori-associated gastropathy. |
priorityDate | 2020-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 654.